# Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy

> **NCT05121415** · — · COMPLETED · sponsor: **Asfendiyarov Kazakh National Medical University** · enrollment: 100 (actual)

## Conditions studied

- Hemorrhagic Stroke
- Eclampsia

## Interventions

- **GENETIC:** SNP analysis of the DNA

## Key facts

- **NCT ID:** NCT05121415
- **Lead sponsor:** Asfendiyarov Kazakh National Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-23
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-01-20
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121415, "Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05121415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*